Abdul M. Bhuiya

Abdul M. Bhuiya

Auto-generated profile, based on publicly available information

Abdul M. Bhuiya

UC Berkeley

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Cell
Verified
Journal Article
Closed access
PFParinaz Fozouni
Parinaz Fozouni
SSSungmin Son
Sungmin Son
MDMaría Díaz de León Derby
María Díaz de León Derby
GKGavin J. Knott
Gavin J. Knott
CGCarley N. Gray
Carley N. Gray
MOMelanie Ott
Melanie Ott

12 February 2026 in PLOS Global Public Health
Verified
Journal Article
Open access
MDMaría Díaz de León Derby
María Díaz de León Derby
ZMZaina L. Moussa
Zaina L. Moussa
CNCarlos F. Ng
Carlos F. Ng
ABAbdul M. Bhuiya
Abdul M. Bhuiya
JCJoana P. Cabrera
Joana P. Cabrera
DFDaniel A. Fletcher
Daniel A. Fletcher
Accurate diagnostics are essential for disease control and elimination efforts. However, access to diagnostics for neglected tropical diseases (NTDs) is hindered by limited healthcare infrastructure in many NTD-endemic regions, as well as by reliance on time- and labor-intensive diagnostic methods, such as smear microscopy. New diagnostic tools that are portable, rapid, low-cost, and meet World Health Organization (WHO) sensitivity and specificity targets are urgently needed to accelerate NTD control and elimination programs. Here, we introduce the NTDscope, a portable microscopy platform that enables point-of-care imaging and automated detection of parasites and other pathogens in patient samples. The NTDscope builds on and extends the capabilities of the LoaScope, a device that turned the camera of a mobile phone into a microscope and used on-board image processing to automatically quantify Loa loa microfilariae burden in whole blood samples. The NTDscope replaces the mobile phone of the LoaScope with a system-on-module (SOM) that enables the integration of multiple imaging modalities in a single package designed to improve robustness and expand applications. In this work, we demonstrate the use of the NTDscope as a portable brightfield, darkfield, and fluorescence microscope for samples including microfilariae and helminth eggs. We also show that the device can be used to quantify molecular assays, such as a lateral flow test and a CRISPR-Cas13a-based assay. The ability to combine the diagnostic capabilities of conventional microscopy with molecular assays and machine learning in a single device could expand access to diagnostics for populations in NTD-endemic areas and beyond.

28 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAbdul M Bhuiya
Abdul M Bhuiya
SASiddhansh Agarwal
Siddhansh Agarwal
CNCarlos F Ng
Carlos F Ng
MOMelanie Ott
Melanie Ott
SSSungmin Son
Sungmin Son
DFDaniel A Fletcher
Daniel A Fletcher
CRISPR-based assays offer sensitive and specific nucleic acid detection for a broad range of diagnostic and surveillance applications. While standard solution-based assays are simple, they typically lack the ability to detect multiple targets individually without the need for more complex instrumentation and multi-step workflows. Surface-based strategies offer greater potential for multiplexing since the identity of a target can be associated with a location on a slide or a specific bead, as in the case of DNA arrays or Luminex bead assays. However, the design principles for optimizing surface-based CRISPR assays have yet to be developed. Here we present a multi-scale analytical framework integrating nanoscale enzyme kinetics, microscale diffusion constraints, and macroscale assay parameters that we use to develop a bead-based Cas13a assay where the bead becomes fluorescent when the target RNA for that bead is detected. The assay, which we call SurfCas, uses surface-bound guide RNAs and reporter RNAs to detect one or more soluble target RNAs in a one-pot assay. We show that SurfCas has a sensitivity approaching bulk reactions, and we demonstrate multiplexed detection of target RNAs in a complex biological matrix. The design principles we establish for surface-based CRISPR assays offer guidance on how to further improve SurfCas sensitivity and scale multiplexed detection of target RNAs in a single reaction.

19 November 2026 in Analytical Chemistry
Verified
Journal Article
Open access
ABAbdul M. Bhuiya
Abdul M. Bhuiya
SASiddhansh Agarwal
Siddhansh Agarwal
CNCarlos F. Ng
Carlos F. Ng
MOMelanie Ott
Melanie Ott
SSSungmin Son
Sungmin Son
DFDaniel A. Fletcher
Daniel A. Fletcher
CRISPR-based assays offer sensitive and specific nucleic acid detection for a broad range of diagnostic and surveillance applications. While standard solution-based assays are simple, they typically lack the ability to detect multiple targets individually without the need for more complex instrumentation and multi-step workflows. Surface-based strategies offer greater potential for multiplexing since the identity of a target can be associated with a location on a surface or with a specific bead, as in the case of DNA arrays or Luminex bead assays, respectively. However, the design principles for optimizing surface-based CRISPR assays have yet to be developed. Here we present a multi-scale analytical framework integrating nanoscale enzyme kinetics, microscale diffusion constraints, and macroscale assay parameters that we use to develop a bead-based Cas13a assay where the bead becomes fluorescent when the target RNA for that bead is detected. The assay, which we call SurfCas, uses surface-bound guide RNAs and reporter RNAs to detect one or more soluble target RNAs in a one-pot assay. We show that SurfCas has a sensitivity approaching bulk reactions, and we demonstrate multiplexed detection of target RNAs in a complex biological matrix. The design principles we establish for surface-based CRISPR assays offer guidance on how to further improve SurfCas sensitivity and scale multiplexed detection of target RNAs in a single reaction.